Psychedelic drugs could help treat the mental health epidemic we'll face after coronavirus
One ecstasy trial reached a milestone when it was approved to treat people with post-traumatic stress disorder in America
Wednesday, May 20, 2020
Most of us have fixed views about drugs like ecstasy or LSD. The majority of us think they are dangerous and should remain illegal. Fear of these drugs is understandable. Their effects are unpredictable and, beyond adjusting the dose, we have limited control over their effects. That’s very different to the ever-popular alcohol and cannabis which are far more predictable in the way they make us feel, behave or think. Trials using psychedelic drugs such as psilocybin, LSD or 3,4-methylene dioxymethamphetamine (known to most of us as ecstasy) are well underway and showing promising results. One such trial reached a milestone when it was approved to treat people with post-traumatic stress disorder in America.